FDA Bans Juul E-cigarettes Sales in US, Experts React

Jul.26.2022
FDA Bans Juul E-cigarettes Sales in US, Experts React
US FDA bans Juul e-cigarettes due to concerns about their marketing towards youth. No evidence they help tobacco consumption.

A report by Medscape reveals that the United States Food and Drug Administration (FDA) has banned the sale of Juul brand e-cigarettes in the country. Dr. Pierre Bizel, a member of Belgium's national anti-tobacco alliance, believes that the primary intention of these products is to attract more smokers and there is no scientific evidence to suggest that e-cigarettes help eliminate tobacco consumption.


The FDA has announced that Juul Labs and their USB-shaped e-cigarettes and flavored nicotine pods have failed to demonstrate that their marketing is "appropriate for the protection of public health." The San Francisco-based startup has been accused of playing a significant role in the surge of youth e-cigarette use, particularly through advertising and marketing aimed at high school students, in an effort to justify its decision.


In 2021, Juul Labs paid $51,000 to fully fund the May-June issue of the American Journal of Health Behavior, which published 11 studies sponsored by Juul that aimed to demonstrate how their products help smokers quit smoking. While all articles underwent peer review (with the twelfth article being rejected), there are questions about the legitimacy of the process from the academic community. The version of the journal has been described by the American Prospect as "taking academic corruption to a new level.


A study that appeared in Tobacco Control in 2021 indicated that less than half of the scientific conclusions in clinical trials sponsored by Juul Labs were accurate. In response to regulatory pressure, the company suspended the sale of flavored pods popular among young people in 2019 and agreed to review its marketing strategies.


MediQuality interviewed Bizel, who is also the Director of Lifestyle Habits Research at the Belgian Health Observatory in Halle.


Is Juul electronic cigarette widely considered a trojan horse that attracts young smokers, according to MediQuality today?


Bizel stated that Juul products were withdrawn from the Belgian market in 2019, but it is clear that they appeal to young people. Resembling a USB stick, the product can be charged on a laptop and comes with separate pods offering different flavors. The product is clearly designed to attract teenagers and young adults, and is not targeted towards responsible adult smokers seeking a way to quit smoking. Such e-cigarettes can only create addiction and then increase the number of smokers. Like other products currently available, such as Puff Bar, the aim remains the same: these fluorescent or candy pink disposable e-cigarettes produce little smoke, are highly discreet, have a very high nicotine content, and attract consumers. After all, these are products manufactured by nicotine sellers.


The Belgian Alliance for Smoke-Free Society believes that e-cigarettes need to attract new customers. However, according to a recent statement by the Belgian Superior Health Council, these products are "not harmless". As such, they pose a risk to young people who need to be protected from their harmful effects.


The device can certainly play a role in smoking cessation, but only in specific circumstances, much like any medication used to aid in treatment. Otherwise, its effectiveness will be very low. Without consultation, doctors, or behavioral support, relapse is almost certain. The device can only be used in a therapeutic environment, much like many other tools. Unfortunately, no e-cigarette manufacturer - Juul or any other company - has applied for marketing authorization for such products to eliminate tobacco consumption. As a result, drug agencies from different countries are unable to assess their positive effects on eliminating tobacco consumption and approve them.


Regardless of what type of cigarette-like aerosol may be presented, no manufacturer can claim that these devices are aids to quitting smoking. Manufacturers are promoting these devices as another way to smoke or as a replacement, but they are not official tools for smoking cessation. While scholars and researchers are attempting to determine the potential benefits of such products, it has not been officially declared as an auxiliary tool to counter tobacco consumption. There is ambiguity involved.


Is the only acceptable electronic cigarette device one that is proven effective and sold in pharmacies, according to MediQuality?


Bizel stated that the manufacturer's strategy does not focus on establishing a presence in the medical field nor gaining the support of tobacco addiction experts or smoking cessation hotlines. Instead, their goal is to create a consumer product that generates as many nicotine-dependent smokers as possible. They have no interest in developing a presence in the treatment industry. Therefore, it is essential to note that the only guarantee of efficacy is through supervision and gradual dose reduction.


This is a market seeking long-term dependence, as there are currently no time restrictions for users of this product. It is important to note, as shown by the national health survey conducted by Belgium's public health research institute, Sciensano, and a survey by the Belgian Cancer Foundation, that 70% of e-cigarette users also smoke traditional cigarettes, making them dual users. This raises questions about the effectiveness of e-cigarettes as a smoking cessation tool, as if they were effective, users would quit smoking altogether. In fact, e-cigarettes increase the overall intake of nicotine, which in turn increases the number of products in circulation and manufacturers' profits. When looking at the big picture, both in Belgium and globally, e-cigarettes have not made any changes to cigarette sales. The same amount of traditional tobacco is still being sold. This new product allows manufacturers to profit from both sides.


Will Juul electronic cigarettes disappear forever, according to MediQuality?


Bizel expressed surprise at the possibility of Juul e-cigarettes returning to the market, but notes that other e-cigarettes are still widely available. A notable recent development in the US is the reduction of nicotine levels in cigarettes by approximately 90%. While this is a significant step towards normalizing cigarette use, it must be properly validated, particularly considering the variety of nicotine types such as salt nicotine and freebase nicotine. This initiative is part of a broader ambitious public health plan to reduce cancer deaths, with President Joe Biden committing to a 50% reduction in cancer deaths within 25 years. However, the five major tobacco companies will need to react, meaning change will not happen overnight.


I am sorry, but as an AI language model, I am already programmed to generate news articles in standard journalistic English. Can you please provide me with a text that needs to be translated?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
New Zealand's Largest Vape Retailer Shosha Faces Advertising Probe Over Offshore Website and Local Fulfilment
New Zealand's Largest Vape Retailer Shosha Faces Advertising Probe Over Offshore Website and Local Fulfilment
New Zealand's Ministry of Health is reviewing its previous assessment of Shosha Global, an international website associated with vape retailer Shosha, after researchers found that the site displayed vaping products while fulfilling orders to New Zealand addresses. Radio New Zealand reported on November 13 that test purchases arrived within three days and shipping documents showed dispatch from Auckland. The researchers also found a store-stock tool listing only New Zealand locations and social media posts carrying local warning labels and cultural references. Shosha, which operates more than 125 stores in New Zealand, says Shosha Global serves overseas customers through an international partnership established in July 2025. No final regulatory finding against the website has been announced.
Regulations
Nov.17
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
On Nov 12, 2026, the European Parliament adopted a resolution on implementing Europe’s Beating Cancer Plan by 447 votes to 66, with 91 abstentions, urging the European Commission to speed up revisions to the Tobacco Products Directive (TPD) and Tobacco Advertising Directive (TAD). Parliament called for broader regulation of e-cigarettes, heated tobacco, nicotine pouches and other emerging nicotine products, proposing measures on packaging, health warnings, flavors, ingredient reporting, online age verification, digital marketing and premarket health impact assessments. EUNews and others reported that the Commission’s Regulatory Scrutiny Board (RSB) issued a negative opinion on the revisions’ impact assessment on Nov 9. The Commission had scheduled the initiative for December 2026, but the reported setback could push the legislative proposal into 2027. No revised official timetable has been announced, and Parliament’s resolution does not amend existing EU law.
Regulations
Nov.19
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30